Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern

E Shlyakhov1, E Rubinstein, I Novikov

  • 1Infectious Diseases Unit, Sheba Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel Hashomer, Israel.

Vaccine
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detectability of a self-illuminating lifeline for self-escape in smoke conditions of an underground mine.

Lighting research & technology (London, England : 2001)·2024
Same author

Impact of azole antifungal treatment on outcome in acute invasive fungal rhinosinusitis with orbitocranial involvement: a surgical perspective.

Rhinology·2023
Same author

First Precision Measurement of the Parity Violating Asymmetry in Cold Neutron Capture on ^{3}He.

Physical review letters·2020
Same author

Assessing anti-estrogenic effects of AHR ligands in primary human and rat endometrial epithelial cells.

Reproductive toxicology (Elmsford, N.Y.)·2020
Same author

Primary endometrial 3D co-cultures: A comparison between human and rat endometrium.

The Journal of steroid biochemistry and molecular biology·2019
Same author

GH3 and RC-4BC cell lines are not suitable as in vitro models to study prolactin modulation and AHR responsiveness in rat pituitary.

Molecular and cellular endocrinology·2019
Same journal

Immunity gaps for several vaccine preventable diseases in Norway.

Vaccine·2026
Same journal

Australians' attitudes to mRNA vaccination in humans and animals: A cross-sectional survey.

Vaccine·2026
Same journal

Immunoproteomics and reverse vaccinology identify a protective T-cell epitope from Fonsecaea pedrosoi for experimental chromoblastomycosis.

Vaccine·2026
Same journal

Retraction notice to "Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled trial" [Vaccine 82 (2026) 128588].

Vaccine·2026
Same journal

Barriers and facilitators to COVID-19 vaccination programme implementation in Ireland: a qualitative study of implementation stakeholders using CFIR.

Vaccine·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
See all related articles

This study tracked cell-mediated immunity after anthrax vaccination using the Anthraxin skin test. Immunity showed a five-phase pattern, with a notable dip around day 30, potentially due to toxin effects.

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Anthrax remains a significant biothreat agent.
  • Effective human live anthrax vaccine (HLAV) development is crucial for biodefense.
  • Understanding post-vaccination immune responses is key to assessing vaccine efficacy.

Purpose of the Study:

  • To characterize the kinetic pattern of cell-mediated immunity following HLAV administration.
  • To investigate the correlation between skin test reactions and vaccine efficacy.
  • To explore potential mechanisms behind observed immune response patterns.

Main Methods:

  • A cohort of 2596 subjects received HLAV via scarification, subcutaneous, or aerosol routes.
  • Anthrax cell-mediated immunity was assessed using the Anthraxin skin test at multiple time points (7-365 days post-vaccination).

Related Experiment Videos

  • Immune response kinetics were analyzed across different vaccination routes.

    • Main Results:

    • A distinct five-phase kinetic curve was observed for Anthraxin skin reactions.
    • Phase II showed an exponential rise peaking at day 15, followed by a decrease in Phase III (days 16-30).
    • A characteristic dip in skin test reactivity around day 30 was noted, potentially linked to macrophage blockade by anthrax toxin.

    Conclusions:

    • The Anthraxin skin test reveals a dynamic, multi-phasic immune response to HLAV.
    • The transient loss of skin test reactivity at day 30 is a key feature potentially related to vaccine strain activity.
    • Observed immune response kinetics correlate with epidemiological data on HLAV protective rates, informing vaccine monitoring and efficacy assessment.